Edition:
United Kingdom

Altimmune Inc (ALT.OQ)

ALT.OQ on NASDAQ Stock Exchange Global Market

0.33USD
17 Aug 2018
Change (% chg)

$-0.01 (-2.97%)
Prev Close
$0.34
Open
$0.35
Day's High
$0.35
Day's Low
$0.30
Volume
100,316
Avg. Vol
116,631
52-wk High
$3.16
52-wk Low
$0.25

Chart for

About

Altimmune, Inc., formerly Pharmathene, Inc., is a clinical-stage immunotherapeutic company. The Company focuses in development of medical counter measures against biological and chemical threats. The Company is involved in development of two next generation anthrax vaccines. It has two proprietary platform technologies,... (more)

Overall

Beta: 2.96
Market Cap(Mil.): $35.38
Shares Outstanding(Mil.): 15.59
Dividend: 29.10
Yield (%): --

Financials

  ALT.OQ Industry Sector
P/E (TTM): 0.08 85.68 32.76
EPS (TTM): 27.25 -- --
ROI: 326.16 1.78 14.61
ROE: 357.56 3.28 16.33

BRIEF-Altimmune Announces Positive Data From Its Phase 2A Study Of Nasovax Intranasal Influenza Vaccine

* ALTIMMUNE ANNOUNCES POSITIVE DATA FROM ITS PHASE 2A STUDY OF NASOVAX INTRANASAL INFLUENZA VACCINE AND PROVIDES AN UPDATE ON ITS PHASE 1B STUDY OF HEPTCELL TARGETED IMMUNOTHERAPY IN CHRONIC HEPATITIS B INFECTION

27 Mar 2018

BRIEF-Altimmune Announces Pre-Clinical Data From Its Sparvax-L Anthrax Vaccine Program

* ALTIMMUNE ANNOUNCES PRE-CLINICAL DATA FROM ITS SPARVAX-L ANTHRAX VACCINE PROGRAM

12 Mar 2018

Competitors

  Price Chg
Green Cross Corp (006280.KS) ₩189,000.00 +10,000.00
Pfizer Inc. (PFE.N) $42.09 +0.67
Panacea Biotec Limited (PNCA.NS) Rs230.60 +4.70
Bavarian Nordic A/S (BAVA.CO) kr.170.05 -6.95
Emergent Biosolutions Inc (EBS.N) $59.27 +0.24
Ibio Inc (IBIO.A) $0.65 -0.03
Soligenix Inc (SNGX.OQ) $1.34 -0.03
Pfenex Inc (PFNX.A) $4.75 -0.06

Earnings vs. Estimates